Ramot, Yuval
Rosenberg, Vered
Zhou, Limei
Harbers, Stephanie
Funding for this research was provided by:
AbbVie
Article History
Received: 23 February 2024
Accepted: 12 April 2024
First Online: 27 May 2024
Declarations
:
: Y Ramot received speaker honoraria, consultancy fees or travel support from Pfizer, AbbVie, Novartis, Janssen, Sanofi, BI, Neopharm, Dexcel Pharma, Taro, and Lilly. V Rosenberg has nothing to declare. L Zhou and S Harbers are employees of AbbVie and may own AbbVie stock and/or options.
: The study was approved by the Maccabi Health Services’ Institutional Review Board, reference number MHS-0013-22, who waived the requirement to obtain any informed consent for this secondary analysis of existing data.